Zdrowie i gospodarka · 31/01/2023

FDA Authorizes Emergency Use of Two In Vitro Diagnostic Devices for Mpox Outbreak Response

The US Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUAs) for two in vitro diagnostic devices to combat the mpox outbreak, following a public health emergency declaration by the Secretary of Health and Human Services in September 2022. The Authorizations were granted after a request from Becton, Dickinson & Company (BD) and DiaCarta, Inc.